E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Price:
1 430.8
INR
-0.26%
Market Cap:
₹271.2B
Income Statement
Earnings Waterfall
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd
Income Statement
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd
Currency: INR
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
0
|
0
|
1 187
|
0
|
0
|
0
|
|
| Revenue |
104 754
N/A
|
124 380
+19%
|
78 960
-37%
|
81 814
+4%
|
84 492
+3%
|
88 501
+5%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(40 672)
|
(48 500)
|
(32 846)
|
(32 655)
|
(33 664)
|
(35 461)
|
|
| Gross Profit |
64 081
N/A
|
75 881
+18%
|
46 114
-39%
|
49 159
+7%
|
50 829
+3%
|
53 040
+4%
|
|
| Operating Income | |||||||
| Operating Expenses |
(49 741)
|
(58 890)
|
(35 267)
|
(37 694)
|
(38 998)
|
(40 166)
|
|
| Selling, General & Administrative |
(26 193)
|
(29 862)
|
(20 996)
|
(14 894)
|
(15 184)
|
(15 388)
|
|
| Depreciation & Amortization |
(5 029)
|
(5 997)
|
(3 841)
|
(3 900)
|
(3 977)
|
(4 056)
|
|
| Other Operating Expenses |
(18 519)
|
(23 031)
|
(10 429)
|
(18 901)
|
(19 837)
|
(20 722)
|
|
| Operating Income |
14 341
N/A
|
16 990
+18%
|
10 847
-36%
|
11 464
+6%
|
11 831
+3%
|
12 874
+9%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(2 711)
|
(3 100)
|
(1 036)
|
(1 256)
|
(755)
|
(420)
|
|
| Non-Reccuring Items |
0
|
0
|
(104)
|
(139)
|
0
|
(520)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
382
|
0
|
0
|
0
|
|
| Total Other Income |
450
|
489
|
(376)
|
477
|
152
|
131
|
|
| Pre-Tax Income |
12 080
N/A
|
14 380
+19%
|
9 713
-32%
|
10 547
+9%
|
11 227
+6%
|
12 066
+7%
|
|
| Net Income | |||||||
| Tax Provision |
(3 263)
|
(4 002)
|
(2 639)
|
(2 850)
|
(3 032)
|
(3 118)
|
|
| Income from Continuing Operations |
8 817
|
10 378
|
7 075
|
7 697
|
8 195
|
8 948
|
|
| Income to Minority Interest |
(449)
|
(472)
|
(261)
|
(255)
|
(264)
|
(249)
|
|
| Net Income (Common) |
8 368
N/A
|
9 906
+18%
|
6 813
-31%
|
7 442
+9%
|
7 931
+7%
|
8 699
+10%
|
|
| EPS (Diluted) |
44.42
N/A
|
52.32
+18%
|
36.43
-30%
|
39.26
+8%
|
41.87
+7%
|
45.88
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
